Medicare Enrolled

Dr. David Burdette, MD

Epilepsy Physician · Grand Rapids, MI
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
275 MICHIGAN ST NE, Grand Rapids, MI 49503
6162677900
In practice since 2006 (19 years)
NPI: 1679648315 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burdette from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burdette? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burdette

Dr. David Burdette is an epilepsy physician in Grand Rapids, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Burdette performed 350 Medicare services across 212 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burdette received a total of $1,197,707 from 18 pharmaceutical and/or device companies across 1521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burdette is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 33% volume in MI $1,197,707 industry payments

Medicare Practice Summary

Medicare Utilization ↗
350
Medicare services
Top 33% in MI for epilepsy physician
212
Unique beneficiaries
$128
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
145 $155 $448
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
65 $108 $298
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
34 $34 $118
EEG with implanted brain neurostimulator generator
This procedure measures brain wave activity using an electroencephalogram (EEG) while an implanted brain neurostimulator generator is present. A report of the findings is provided.
33 $67 $251
Brain stimulator programming, additional 15 minutes
Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service.
31 $33 $103
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
14 $187 $434
Video EEG monitoring, 2-12 hours
Continuous monitoring of brain wave activity combined with video recording for a duration of 2 to 12 hours.
14 $480 $1,345
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
14 $105 $295
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,197,707
Total received (2018-2024)
Avg $171,101/year across 7 years
Top 11% in MI for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
1,521
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,020,125 (85.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$161,849 (13.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,733 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$229,412
2023
$218,371
2022
$153,154
2021
$177,985
2020
$170,390
2019
$150,002
2018
$98,393

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$96,733
JAZZ PHARMACEUTICALS INC.
$75,943
NEUROPACE, INC.
$25,693
SK Life Science, Inc.
$20,274
CATALYST PHARMACEUTICALS, INC.
$10,636
Neurelis, Inc.
$116
Ipsen Biopharmaceuticals, Inc
$17
Top 3 companies account for 86.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$565,142
SK Life Science, Inc.
$154,434
JAZZ PHARMACEUTICALS INC.
$151,904
NEUROPACE, INC.
$135,637
Greenwich Biosciences, Inc.
$93,250
Eisai Inc.
$34,772
Sunovion Pharmaceuticals Inc.
$16,842
NeuroPace, Inc.
$16,092
EISAI INC.
$14,826
CATALYST PHARMACEUTICALS, INC.
$10,636
Medtronic USA, Inc.
$1,510
Catalyst Pharmaceuticals, Inc.
$1,366
LivaNova USA, Inc.
$778
Neurelis, Inc.
$300
AQUESTIVE THERAPEUTICS, INC.
$125
Medtronic, Inc.
$43
Supernus Pharmaceuticals, Inc.
$36
Ipsen Biopharmaceuticals, Inc
$17
Top 3 companies account for 72.8% of all-time payments
Associated products mentioned in payments ›
ACTIVA · APTIOM · Briviact · Cenobamate · Dysport · EPIDIOLEX · Epidiolex · FYCOMPA · Fintepla · Fycompa · Nayzilam · OXTELLAR XR · RNS Neurostimulator Kit · RNS System · SYMPAZAN · VALTOCO · VISUALASE · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · Vimpat · XCOPRI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in epilepsy physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for an epilepsy physician in Grand Rapids?
Compare epilepsy physicians in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians within 10 mi
5
Per 100K population
0.8
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Burdette is a remote monitoring specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 11% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Burdette experienced with veeg monitoring, 12-26 hours with review?
Based on Medicare claims data, Dr. Burdette performed 145 veeg monitoring, 12-26 hours with review services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burdette receive payments from pharmaceutical companies?
Yes. Dr. Burdette received a total of $1,197,707 from 18 companies across 1,521 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burdette's costs compare to other epilepsy physicians in Grand Rapids?
Dr. Burdette's average Medicare payment per service is $128. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burdette) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →